Physician

Jessica Gold, MD/PHD

According to 2025 Medicare claims, Jessica Gold, MD/PHD (NPI: 1922412295) practices medical genetics and genomics in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NORTH SHORE-LIJ MEDICAL PC (NPI: 1053688572; TIN: 113506359) and primary practice location at 11021-5501. Gold is affiliated with the Delaware Valley ACO (ACO ID: A2024) and Northwell Health ACO (ACO ID: A3030), participating under the MSSP model.

Gold's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 30 traditional Medicare patients, billed 59 HCPCS/CPT codes, and received $6,453 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 153 prescription claims across 11 beneficiaries totaling $4,680,690 in drug costs, led by Nexviazyme (Avalglucosidase Alfa-Ngpt). Open Payments data shows 1 records totaling $159. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $13,161 to $4,680,690. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.2K$6.5K2024 Medicare payment: $6,453 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20243059$6,453

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.7M2015 Drug cost: $13,161 (USD; Tot_Drug_Cst)2016 Drug cost: $15,533 (USD; Tot_Drug_Cst)2017 Drug cost: $21,588 (USD; Tot_Drug_Cst)2018 Drug cost: $12,224 (USD; Tot_Drug_Cst)2023 Drug cost: $152,471 (USD; Tot_Drug_Cst)2024 Drug cost: $4,680,690 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201543197$13,161
201631236$15,533
201734275$21,588
201819139$12,224
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20231124$152,471
202411153$4,680,690

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1515$167
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1322$152
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's1218$15

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NexviazymeAvalglucosidase Alfa-Ngpt62995$1,880,174
ElapraseIdursulfase14392$1,795,711
LumizymeAlglucosidase Alfa13364$611,412
Dextrose In WaterDextrose 5 % In Water41561$255

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.1$159SANOFI US SERVICES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jessica Gold, MD/PHD?

Tedicare shows public-source Medicare data for Jessica Gold, MD/PHD (NPI 1922412295), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jessica Gold, MD/PHD have ACO affiliation data?

Jessica Gold, MD/PHD is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024) and Northwell Health ACO (MSSP, ACO ID A3030).

What billing organization is linked to Jessica Gold, MD/PHD?

Jessica Gold, MD/PHD is linked to NORTH SHORE-LIJ MEDICAL PC (billing NPI 1053688572) in the available physician profile data.

Does Jessica Gold, MD/PHD have Open Payments data?

Jessica Gold, MD/PHD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.